CytomX Therapeutics (United States)
- Research works
- 49 ▲ 96% vs 2013–17
- Citations
- 862 17.5 per fractional work
- Top-10% rate
- 22.4% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: CytomX Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.2×. Every wedge is a field page.
Who are the top researchers at CytomX Therapeutics (United States)?
Ranked on the composite score, Marcia Belvin lead among researchers whose main affiliation is CytomX Therapeutics (United States).
- 1 Marcia Belvin United States · #388,694 worldwide 94 citations · 31 works
Which keywords describe research at CytomX Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Angiogenesis, Cancer and PET Imaging.
- PD-1 and PD-L1
- High-Throughput Analysis
- Cell Adhesion
- Immunosuppression
- Immunity
- Antigen Presentation
- Chimeric Antigen Receptor
- Radiopharmaceuticals
- Cancer Treatment
- Targeted Therapy
- Immune System
- Inflammation
- HER2
- Cancer Therapy
- Tumor Microenvironment
- Chemotherapy
- PET Imaging
- Angiogenesis
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Cancer
- Cancer Immunotherapy
- Immunotherapy
- Breast Cancer
- Metastatic
- Trastuzumab
- Glycans
- Extracellular Matrix
- Tumor Regression
- Radioimmunotherapy
- CAR T Cells
- Innate Immunity
- Dendritic Cells
- Fibroblast Activation Protein
- Tumor Targeting
- Integrins
- Immune Checkpoint Blockade
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation15▲ 141×2 topics
- Monoclonal Antibodies12▲ 176×3 topics
- Therapeutic Antibodies12▲ 194×2 topics
- Antibody Engineering12▲ 246×1 topic
- Fc Receptors12▲ 246×1 topic
- Angiogenesis6▲ 29×5 topics
- Cancer5▲ 7.8×3 topics
- PET Imaging5▲ 45×3 topics
- Cancer Immunotherapy5▲ 66×2 topics
- Chemotherapy4▲ 11×6 topics
- Immunotherapy4▲ 12×7 topics
- Tumor Microenvironment4▲ 22×4 topics
- Breast Cancer4▲ 28×4 topics
- Cancer Therapy4▲ 12×5 topics
- Metastatic4▲ 117×2 topics
- HER24▲ 241×1 topic
- Trastuzumab4▲ 171×1 topic
- Inflammation3▲ 2.9×6 topics
- Glycans3▲ 82×1 topic
- Immune System3▲ 20×1 topic
- Extracellular Matrix3▲ 27×2 topics
- Targeted Therapy3▲ 30×4 topics
- Tumor Regression3▲ 75×2 topics
- Cancer Treatment3▲ 22×2 topics
- Radioimmunotherapy3▲ 140×1 topic
- Radiopharmaceuticals3▲ 140×1 topic
- CAR T Cells2▲ 112×1 topic
- Chimeric Antigen Receptor2▲ 112×1 topic
- Innate Immunity2▲ 13×2 topics
- Antigen Presentation2▲ 45×2 topics
- Dendritic Cells2▲ 38×1 topic
- Immunity2▲ 13×1 topic
- Fibroblast Activation Protein2▲ 82×1 topic
- Immunosuppression2▲ 36×1 topic
- Tumor Targeting2▲ 31×3 topics
- Cell Adhesion2▲ 46×1 topic
- Integrins2▲ 67×1 topic
- High-Throughput Analysis2▲ 69×1 topic
- Immune Checkpoint Blockade2▲ 59×1 topic
- PD-1 and PD-L12▲ 59×1 topic
Which research topics does CytomX Therapeutics (United States) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Advanced Biosensing Techniques and Applications and Click Chemistry and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 2 Immunotherapy and Immune Responses Immunology 1 works
- 3 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
- 4 Click Chemistry and Applications Organic Chemistry 1 works
- 5 Chemokine receptors and signaling Oncology 0 works
- 6 HER2/EGFR in Cancer Research Oncology 0 works
- 7 CAR-T cell therapy research Oncology 0 works
- 8 Toxin Mechanisms and Immunotoxins Immunology 0 works
- 9 Parathyroid Disorders and Treatments Nephrology 0 works
- 10 Cancer Research and Treatments Biotechnology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CytomX Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 96% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.